Anixa Biosciences (ANIX) Current Leases (2020 - 2026)
Anixa Biosciences' (ANIX) quarterly Current Leases came in at $44000.0 in Q2 2026, up 18.92% YoY from $37000.0 in Q2 2025, and up 7.32% on a QoQ basis from $41000.0 in Q4 2025.
Anixa Biosciences (ANIX) Current Leases (2020 - 2026) Analysis & Trends
Anixa Biosciences (ANIX) has 7 years of Current Leases data on file, last reported at $44000.0 in Q2 2026.
- Quarterly Current Leases rose 18.92% year-over-year to $44000.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $44000.0 (up 18.92% YoY) and the FY2025 annual result came in at $41000.0, up 41.38% from the prior year.
- Current Leases rose to $44000.0 in Q2 2026, from $41000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $56000.0 in Q2 2024 to a low of $24000.0 in Q3 2024.
- A 5-year average of $42882.4 and a median of $44000.0 in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases jumped 316.39% — and 2024, when it slumped 52.94%.
- Tracing ANIX's Current Leases over 5 years: stood at $46000.0 in 2022, then grew by 13.04% to $52000.0 in 2023, then tumbled by 44.23% to $29000.0 in 2024, then surged by 41.38% to $41000.0 in 2025, then advanced by 7.32% to $44000.0 in 2026.
- The last three Current Leases figures came in at $44000.0 (Q2 2026), $41000.0 (Q4 2025), and $39000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Anixa Biosciences | 125.30 Mn | 125.30 Mn | - | 44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 44,000.00 |
| Oct 31, 2025 | 41,000.00 |
| Jul 31, 2025 | 39,000.00 |
| Apr 30, 2025 | 37,000.00 |
| Jan 31, 2025 | 36,000.00 |
| Oct 31, 2024 | 29,000.00 |
| Jul 31, 2024 | 24,000.00 |
| Apr 30, 2024 | 56,000.00 |
| Jan 31, 2024 | 54,000.00 |
| Oct 31, 2023 | 52,000.00 |
| Jul 31, 2023 | 51,000.00 |
| Apr 30, 2023 | 49,000.00 |
| Jan 31, 2023 | 47,000.00 |
| Oct 31, 2022 | 46,000.00 |
| Jul 31, 2022 | 44,000.00 |
| Apr 30, 2022 | 39,000.00 |
| Jan 31, 2022 | 41,000.00 |
| Oct 31, 2021 | 39,000.00 |
| Jul 31, 2021 | 10,567.00 |
| Apr 30, 2021 | 25,964.00 |